New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
10:00 EDTRADRite Aid benefiting from generic rebid and Cymbalta launch, says Cleveland
Cleveland Research said Rite Aid's gross profits are benefiting from a recent RFP for its generic business which will likely result in savings of 3% and the Cymbalta generic launch that is running above expectations, which should offset reimbursement pressures.
News For RAD From The Last 14 Days
Check below for free stories on RAD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 25, 2014
13:13 EDTRADEinhorn bought Lam Research shares, sold Rite Aid last quarter
Subscribe for More Information
July 24, 2014
16:09 EDTRADRite Aid names Darren Karst as executive VP, CFO
Subscribe for More Information
16:05 EDTRADRoundy's CFO Karst leaves for Rite-Aid, names Michael Turzenski as CFO
Roundy’s (RNDY) announced that Darren Karst, Roundy’s executive VP and CFO will be leaving the company to join Rite Aid (RAD) as its executive VP and CFO. Karst will remain with Roundy’s through August 9. Michael Turzenski, currently Roundy’s group VP and Chief Accounting Officer, has been appointed group VP, CFO by Roundy’s board. Turzenski has served as group VP, Chief Accounting Officer since February 2012. Turzenski joined Roundy’s in 2007 as VP, controller.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use